Industry 4.0 requires comprehensive data collection in order to control highly automated process sequences in complex production environments. One example is the cultivation of living cells. But digitalizing and networking biotech production equipment is a huge challenge: relevant standards have yet to be established, and biology has a dynamic all its own.
Using fully automated equipment for producing stem cells, Fraunhofer researchers have managed to adjust the process control to cell growth – delivering an adaptive system that is suitable for use in a number of sectors.
Industry 4.0 requires comprehensive data collection in order to control highly automated process sequences in complex production environments. One example is the cultivation of living cells. But digitalizing and networking biotech production equipment is a huge challenge: relevant standards have yet to be established, and biology has a dynamic all its own. Using fully automated equipment for producing stem cells, Fraunhofer researchers have managed to adjust the process control to cell growth – delivering an adaptive system that is suitable for use in a number of sectors.
The term industry 4.0 is generally associated with the manufacturing of cars, machinery or industrial goods. But, as the partners (see box) in the StemCellFactory collaborative project show, the comprehensive networking of machines and products is also making headway in biotechnology. This is a particular challenge, because this field deals not with solid components but with living objects that – unlike screws or gears – change and multiply. Networked process control needs to take this into account and be able to adjust the process accordingly in real time.
The StemCellFactory project partners have set up a fully automated production line for culturing stem cells, which can develop into any kind of cell found in the body; experts call them induced pluripotent stem cells (iPS cells). Researchers from the Fraunhofer Institute for Production Technology IPT will be presenting the production line at the Hannover Messe Preview on January 27 and at the Hannover Messe (Hall 17, Booth C18 and Hall 2, Booth C16) from April 25 to 29. Medical expertise was provided by experts from the university clinics in Bonn and Aachen, among others. iPS cells such as these are necessary in the development of medications used in personalized medicine. They are obtained from adult body cells such as human skin or blood cells. First, a doctor takes cells from a patient. Next, these cells are reprogrammed to become iPS cells by adding certain substances. This causes the cells to revert to an embryonic state, from which they can theoretically differentiate into any cell type – even heart or nerve cells, which, owing to the risk to the patient, cannot be obtained by means of a biopsy. The pharmaceutical industry uses these cells for medical tests: since they contain the patient’s own genetic information, the cells are very useful for determining which medications will be effective.
Fully automated, modular production platform
To date, iPS cells are grown by lab specialists in a painstaking, time-consuming process. The number and quality of iPS cells that can be cultured depend entirely on how experienced the lab technician is. This is why the project aimed to develop fully automated, modular equipment that achieves both a high throughput and a consistently high quality of stem cells. The IPT experts were given the task of developing both the equipment and its control mechanisms. They faced a number of challenges, the first being how to network the various biotech devices – liquid handling robot, a microscope, an incubator, and the automatic magazine for storing cells and containers – in a way that permitted the use of process-control technology in the first place. “Despite the industry’s efforts to establish uniform interfaces for lab automation equipment, there is as yet no international standard for networking the devices used,” says IPT developer Michael Kulik. “That means plug and play is not an option, so we first had to develop a standard of our own before we could integrate everything.”
This approach achieved a very high degree of networking in order to allow the process-control technology and the lab equipment to exchange information. That in turn was the prerequisite for the equipment to adjust extremely flexibly to the biological processes at work. Cell growth is the decisive factor. As the cells grow in the cell culture vessels, they divide again and again. To ensure conditions don’t get too cramped for the cells, from time to time the pipette feeder robot has to distribute them among a larger number of fresh, empty cell culture vessels.
To this end, the microscope developed at the IPT regularly examines the growth density inside the cell culture vessels. Once a critical density is reached, the microscope sends out an instruction to rehouse the cells. “This is an example of the product, in this case the growing stem cells, determining how the overall process unfolds,” says Kulik. In other words: production has the capability to adjust itself to the present situation.
A user interface makes it easy to control each device included in the equipment. If the user needs to alter or add to the equipment’s process steps, there are pre-programmed blocks of instructions that they can simply drag into or out of the control menu. Staff can choose whether to operate the equipment in fully automated or manual mode.
The technology developed as part of the StemCellFactory project can also be applied in other situations, for instance in tissue engineering and the production of tissue models. It would also be possible to use it to manufacture gears, screws, engines, etc. in a fully automated way. The software is scalable, making it suitable for small and large production facilities alike. Since the programming is extremely flexible, the process-control technology can be transferred to any other production setup in need of adaptive control on the basis of current measurement data. During the Hannover Messe, visitors will be treated to a live demonstration of how the StemCellFactory is controlled remotely, specifically from Bonn.
Read more: Adjusting production processes in real time
The Latest on: Industry 4.0
via Google News
The Latest on: Industry 4.0
- Industrial Revolution 4.0 can help boost construction industryon October 9, 2020 at 9:00 am
Although the construction industry is considered one of the major drivers of every nation's economy, its efficacy can be further boosted through the involvement of IR 4.0, like in the manufacturing ...
- Sitcom partners with Airspan Networks to supply 5G for Industry 4.0 applicationson October 9, 2020 at 8:14 am
Siticom, the German subsidiary of IT services group Devoteam, has signed a partnership agreement with Airspan Networks to supply 5G wireless connectivity for Industry 4.0 applications in Germany.
- Italy Aug industry output rises much more than expected, as post-lockdown recovery continueson October 9, 2020 at 3:50 am
Italian industrial output rose a much stronger-than-expected 7.7% in August from the month before, data showed on Friday, a fourth consecutive monthly gain following the end of the country's ...
- Worldwide Industry for Automated Guided Vehicles to 2027 - Incorporation of Industry 4.0 Presents Opportunities - ResearchAndMarkets.comon October 9, 2020 at 3:20 am
The "Automated Guided Vehicle Market by Type, Navigation Technology, Application, Industry and Mode of Operation: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ...
- Virtual format for Automation Alley's Integr8 conference on Nov. 9-10 creates new opportunities to showcase urgency of Industry 4.0 integrationon October 9, 2020 at 3:00 am
PRNewswire-PRWeb/ -- The COVID-19 pandemic has brought to light the urgent need for Industry 4.0 adoption and integration within the ...
- What’s Preventing Industry 4.0 from Taking Hold? (And What Can You Do About It?)on October 8, 2020 at 7:30 am
Industry 4.0 is a decade in the making yet is still seemingly out of reach for many manufacturing organizations. Why are so many middle-market companies still failing to take advantage of innovations ...
- Industry 4.0 - Use Cases and Telco Monetization Strategieson October 8, 2020 at 3:40 am
Disclaimer | Commerce Policy | Made In NYC | Stock quotes by finanzen.net New York, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Industry 4.0 - Use Cases ...
- EasyMile: 5 Reasons Autonomous Technology is a Game Changer for Industry 4.0on October 7, 2020 at 6:28 am
Autonomous technology already used for public transport is taking over. With its ability to cross over to material handling operations, ...
- Industry 4.0 gives manufacturing a lifton October 6, 2020 at 5:01 pm
As the economy undergoes a post-pandemic recovery and domestic activities gradually begin to pick up speed, the manufacturing industry in Thailand is looking to Industry 4.0 to boost the industrial ...
- The Coming Of Age Of Industry 4.0 In A Post-Pandemic Worldon October 6, 2020 at 4:03 am
The first significant steps will be inexpensive, software-oriented, easy to deploy technologies that mark a point of no return for manufacturers in a more resilient and efficient manufacturing world.
via Bing News